Drug Repurposing of Pharmaceutical Products and Antimicrobial Discovery

The process of identifying new therapeutic uses for existing medications is known as drug repurposing. It's a good way to find or develop new drug compounds with different pharmacological applications. In recent years, numerous pharmaceutical companies have used the drug reformulation technique in their Research and Development of pharmaceuticals programmes to produce new medications based on the identification of new biological drug targets. This technique is extremely efficient, saves time, minimal cost, and has a low risk of failure. It boosts a drug's therapeutic value and its success rate. As a result, drug repositioning is a viable alternative to the standard drug development procedure. Identifying novel molecular compounds by de novo approach of drug is challenging, tedious and costly endeavor. To identify novel use of drug molecules many laboratory and drug interactions is been done. It is thus thought to be a developing method in existing drug, which have previously been shown safe in people and are in turn used to tackle rare and complicated diseases. Biopharmaceutical businesses have struggled to get the anticipated results when aiming to boost productivity through novel discovery technologies. Repositioning existing medications for new indications could help the industry achieve productivity gains. More firms are looking for repositioning options in their existing pharmacopoeia, and the number of drug repurposing has many success stories.